ABSTRACT

Aim:

To investigate the effectiveness of preperitoneal mesh placement with anterior approach in incarcerated femoral hernia and to reveal morbidity and recurrence rates.

Methods:

Twenty-three patients with incarcerated inguinal hernia, who were admitted to our emergency surgery clinic between the years 2009 and 2012 and found to have incarcerated femoral hernia during exploration, were included in the study. All patients underwent inguinal transverse incision suitable for anterior approach. By cutting transversalis fascia, polypropylene mesh was placed preperitoneally between Cooper‘s ligament and the conjoint tendon.

Objective:

Approximately 170-300 million people worldwide are estimated to be infected with HCV. HCV is the causative agent about 20% of acute infections and %70 of chronic active hepatitis cases. Asymptomatic course and leading chronicity is the most important problem in HCV cases. The rapid replication of the virus and RNA transcription errors have important role in chronicity. As a result of errors, different genetic sequences of HCV appear. These genotypes 1a, 1b, 2a, 2b, 3a may present worldwide, while the genotypes 4, 5, 6 were only in certain regions. In this study, we investigated HCV genotypes and ALT, AST profiles of newly diagnosed and untreated blood samples obtained from 100 patients positive for HCV RNA admitted to Necip Fazil Kahramanmaras City Hospital microbiology laboratory.

Conclusion:

Preperitoneal mesh placement with anterior approach in incarcerated femoral hernia as an emergency is safe in terms of complications and recurrence either with or without intestinal resection.